Kazakhstan vs Pakistan: Hepatitis B surface antigen (HBsAg) prevalence
Kazakhstan
0.2%
in 2024
Pakistan
0.2%
in 2024
Kazakhstan rank
82nd
Pakistan rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Kazakhstan
- Pakistan
How they compare
Kazakhstan currently reports 0.2% against 0.2% in Pakistan, a difference of 0.0%.
Across all 10 years both countries report, Pakistan has been ahead every year.
Kazakhstan ranks 82nd and Pakistan ranks 82nd of 194 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kazakhstan | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Pakistan |
| 2020s | 0.2% | 0.2% | 0.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Kazakhstan or Pakistan?
- Kazakhstan, at 0.2% against 0.2% in Pakistan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Kazakhstan and Pakistan?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Pakistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Kazakhstan and Pakistan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Kazakhstan ranks 82nd and Pakistan ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.